Trial intelligence / Profile preview

Tiotropium vs Ipratropium in COPD

NCT00274040Phase 3Completed

Sponsor
Boehringer Ingelheim
Start
Jul 2002
Primary completion
Mar 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Jul 2002; status: completed.

02

Drugs

tiotropium
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00274040.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00274040.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call